Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 636

2.

Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Starks AM, Schoeb TR, Tamplin ML, Parveen S, Doyle TJ, Bomeisl PE, Escudero GM, Gulig PA.

Infect Immun. 2000 Oct;68(10):5785-93.

3.

Genotype is correlated with but does not predict virulence of Vibrio vulnificus biotype 1 in subcutaneously inoculated, iron dextran-treated mice.

Thiaville PC, Bourdage KL, Wright AC, Farrell-Evans M, Garvan CW, Gulig PA.

Infect Immun. 2011 Mar;79(3):1194-207. doi: 10.1128/IAI.01031-10.

4.

Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice.

Cerveny KE, DePaola A, Duckworth DH, Gulig PA.

Infect Immun. 2002 Nov;70(11):6251-62.

5.

Analysis of Vibrio vulnificus from market oysters and septicemia cases for virulence markers.

DePaola A, Nordstrom JL, Dalsgaard A, Forslund A, Oliver J, Bates T, Bourdage KL, Gulig PA.

Appl Environ Microbiol. 2003 Jul;69(7):4006-11.

6.

Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection.

Hor LI, Chang YK, Chang CC, Lei HY, Ou JT.

Microbiol Immunol. 2000;44(11):871-8.

7.

Role of GacA in virulence of Vibrio vulnificus.

Gauthier JD, Jones MK, Thiaville P, Joseph JL, Swain RA, Krediet CJ, Gulig PA, Teplitski M, Wright AC.

Microbiology. 2010 Dec;156(Pt 12):3722-33. doi: 10.1099/mic.0.043422-0.

PMID:
20817642
8.

Characterization of clinical and environmental types of Vibrio vulnificus isolates from Louisiana oysters.

Han F, Pu S, Hou A, Ge B.

Foodborne Pathog Dis. 2009 Dec;6(10):1251-8. doi: 10.1089/fpd.2009.0343.

PMID:
19743928
9.

Molecular Pathogenesis of Vibrio vulnificus.

Gulig PA, Bourdage KL, Starks AM.

J Microbiol. 2005 Feb;43 Spec No:118-31. Review.

PMID:
15765065
10.
11.

In vitro and in vivo antimicrobial activity of water-soluble chitosan oligosaccharides against Vibrio vulnificus.

Lee BC, Kim MS, Choi SH, Kim KY, Kim TS.

Int J Mol Med. 2009 Sep;24(3):327-33.

PMID:
19639224
12.

Vibrio vulnificus damages macrophages during the early phase of infection.

Tsuchiya T, Mitsuo E, Hayashi N, Hikita Y, Nakao H, Yamamoto S, Miyamoto K, Tsujibo H.

Infect Immun. 2007 Sep;75(9):4592-6.

13.

Plasmid diversity in Vibrio vulnificus biotypes.

Roig FJ, Amaro C.

Microbiology. 2009 Feb;155(Pt 2):489-97. doi: 10.1099/mic.0.023424-0.

PMID:
19202097
14.

Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.

Chiang SR, Tang HJ, Chang PC, Cheng KC, Ko WC, Chen CH, Chuang YC.

J Microbiol Immunol Infect. 2007 Apr;40(2):123-33.

PMID:
17446960
15.

Role of iron in human serum resistance of the clinical and environmental Vibrio vulnificus genotypes.

Bogard RW, Oliver JD.

Appl Environ Microbiol. 2007 Dec;73(23):7501-5. Erratum in: Appl Environ Microbiol. 2008 May;74(10):3322.

17.

Phase variation, capsular polysaccharide, pilus and flagella contribute to uptake of Vibrio vulnificus by the Eastern oyster (Crassostrea virginica).

Srivastava M, Tucker MS, Gulig PA, Wright AC.

Environ Microbiol. 2009 Aug;11(8):1934-44. doi: 10.1111/j.1462-2920.2009.01916.x.

PMID:
19689704
18.

Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus.

Stelma GN Jr, Reyes AL, Peeler JT, Johnson CH, Spaulding PL.

Appl Environ Microbiol. 1992 Sep;58(9):2776-82.

19.

Vibrio vulnificus rtxE is important for virulence, and its expression is induced by exposure to host cells.

Lee BC, Lee JH, Kim MW, Kim BS, Oh MH, Kim KS, Kim TS, Choi SH.

Infect Immun. 2008 Apr;76(4):1509-17. doi: 10.1128/IAI.01503-07.

20.

A conserved GTPase YchF of Vibrio vulnificus is involved in macrophage cytotoxicity, iron acquisition, and mouse virulence.

Chen YC, Chung YT.

Int J Med Microbiol. 2011 Aug;301(6):469-74. doi: 10.1016/j.ijmm.2011.02.002.

PMID:
21570909

Supplemental Content

Support Center